Takeda Pharmaceutical Company Limited:企業の戦略・SWOT・財務分析

◆英語タイトル:Takeda Pharmaceutical Company Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4878
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:73
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Takeda Pharmaceutical Company Limited – Strategy, SWOT and Corporate Finance Report
Summary

Takeda Pharmaceutical Company Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Takeda Pharmaceutical Company Limited (Takeda or ‘the company’) is a research-based global company with its main focus on pharmaceuticals. The company classifies its business into Ethical Drugs, Consumer Healthcare and Other Businesses. It offers a range of ethical drugs, over-the-counter (OTC) products and quasi drugs under central nervous system (CNS), oncology, gastrointestinal and vaccines therapeutic areas. It offers its products under the brands Velcade (bortezomib), Ninlaro (ixazomib), Adcetris (brentuximab vedotin), Trintellix (vortioxetine), Dexilant (dexlansoprazole), Takecab (vonoprazan), Amitiza (lubiprostone), Entyvio (vedolizumab), Nesina (alogliptin benzoate), Uloric (febuxostat) and Colcrys (colchicine). The company markets its products in about 100 countries. Takeda is headquartered in Osaka, Japan.

Scope

- Detailed information on Takeda Pharmaceutical Company Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Takeda Pharmaceutical Company Limited in the form of a SWOT analysis
- An in-depth view of the business model of Takeda Pharmaceutical Company Limited including a breakdown and examination of key business segments
- Intelligence on Takeda Pharmaceutical Company Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Takeda Pharmaceutical Company Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Takeda Pharmaceutical Company Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Takeda Pharmaceutical Company Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Takeda Pharmaceutical Company Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Takeda Pharmaceutical Company Limited: Company Overview
Takeda Pharmaceutical Company Limited: Overview and Key Facts
Takeda Pharmaceutical Company Limited: Overview
Takeda Pharmaceutical Company Limited: Key Facts
Takeda Pharmaceutical Company Limited: Key Employees
Takeda Pharmaceutical Company Limited: Key Employee Biographies
Takeda Pharmaceutical Company Limited: Major Products and Services
Takeda Pharmaceutical Company Limited: Company History
Takeda Pharmaceutical Company Limited: Management Statement
Takeda Pharmaceutical Company Limited: Locations and Subsidiaries
Takeda Pharmaceutical Company Limited: Key Competitors
Takeda Pharmaceutical Company Limited: Company Analysis
Takeda Pharmaceutical Company Limited: Business Description
Takeda Pharmaceutical Company Limited: SWOT Analysis
Takeda Pharmaceutical Company Limited: SWOT Overview
Takeda Pharmaceutical Company Limited: Strengths
Takeda Pharmaceutical Company Limited: Weaknesses
Takeda Pharmaceutical Company Limited: Opportunities
Takeda Pharmaceutical Company Limited: Threats
Takeda Pharmaceutical Company Limited: Corporate Financial Deals Activity
Takeda Pharmaceutical Company Limited: Financial Deals Overview
Takeda Pharmaceutical Company Limited: Targets and Partners
Takeda Pharmaceutical Company Limited: Top Deals 2016 – 2020YTD*
Takeda Pharmaceutical Company Limited: Advisors
Takeda Pharmaceutical Company Limited: Top Legal Advisors
Takeda Pharmaceutical Company Limited: Top Financial Advisors
Takeda Pharmaceutical Company Limited: Mergers and Acquisitions
Takeda Pharmaceutical Company Limited: Corporate Venturing
Takeda Pharmaceutical Company Limited: Capital Raising
Takeda Pharmaceutical Company Limited: Partnership
Takeda Pharmaceutical Company Limited: Divestments
Takeda Pharmaceutical Company Limited: Recent Developments
Takeda Pharmaceutical Company Limited: News and Events Summary
Takeda Pharmaceutical Company Limited: Business Expansion
Takeda Pharmaceutical Company Limited: Contracts
Takeda Pharmaceutical Company Limited: Financial Performance
Takeda Pharmaceutical Company Limited: Market Developments
Takeda Pharmaceutical Company Limited: Regulatory and Legal Events
Takeda Pharmaceutical Company Limited: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Takeda Pharmaceutical Company Limited: Key Facts
Table 2: Takeda Pharmaceutical Company Limited: Key Employees
Table 3: Takeda Pharmaceutical Company Limited: Company History
Table 4: Takeda Pharmaceutical Company Limited: Locations and Subsidiaries
Table 5: Takeda Pharmaceutical Company Limited: Key Competitors
Table 6: Takeda Pharmaceutical Company Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Takeda Pharmaceutical Company Limited: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Takeda Pharmaceutical Company Limited: M&A Average Deal Size - Value (US$m)
Table 9: Takeda Pharmaceutical Company Limited: Targets and Partners
Table 10: Takeda Pharmaceutical Company Limited: Top Deals 2016 - 2020YTD*
Table 11: Takeda Pharmaceutical Company Limited: Legal Advisor Ranking by Value (US$m)
Table 12: Takeda Pharmaceutical Company Limited: Financial Advisor Ranking by Value (US$m)
Table 13: Takeda Pharmaceutical Company Limited: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Takeda Pharmaceutical Company Limited: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Takeda Pharmaceutical Company Limited: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 16: Takeda Pharmaceutical Company Limited: Corporate Venturing by Geography (2016 - YTD*2020)
Table 17: Takeda Pharmaceutical Company Limited: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 18: Takeda Pharmaceutical Company Limited: Capital Raising by Deal Type (2016 - YTD*2020)
Table 19: Takeda Pharmaceutical Company Limited: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 20: Takeda Pharmaceutical Company Limited: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 21: Takeda Pharmaceutical Company Limited: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 22: Takeda Pharmaceutical Company Limited: Divestments by Geography (2016 - YTD*2020)
Table 23: Takeda Pharmaceutical Company Limited: News and Events Summary
Table 24: Takeda Pharmaceutical Company Limited: Business Expansion
Table 25: Takeda Pharmaceutical Company Limited: Contracts
Table 26: Takeda Pharmaceutical Company Limited: Financial Performance
Table 27: Takeda Pharmaceutical Company Limited: Market Developments
Table 28: Takeda Pharmaceutical Company Limited: Regulatory and Legal Events
Table 29: Takeda Pharmaceutical Company Limited: Research & Development

★海外企業調査レポート[Takeda Pharmaceutical Company Limited:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taiheiyo Cement Corporation (5233):企業の財務・戦略的SWOT分析
    Taiheiyo Cement Corporation (5233) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Toyota Tsusho Corporation (8015)-エネルギー分野:企業M&A・提携分析
    Summary Toyota Tsusho Corporation (Toyota Tsusho) is a diversified general trading and project management company. The company trades steel, aluminum, machinery, electronics, energy, chemicals, and other consumer products. It also provides passenger cars, buses, motorcycles, trucks, used vehicles, e …
  • ICICI Bank Ltd:企業のM&A・事業提携・投資動向
    ICICI Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICICI Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Malee Group Public Company Limited:企業の戦略・SWOT・財務分析
    Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Calian Group Ltd (CGY):企業の財務・戦略的SWOT分析
    Summary Calian Group Ltd (CTL), formerly Calian Technologies Ltd, is a diversified company that offers professional services in the areas of health, training, information technology, engineering and manufacturing. The company’s health division offers occupational health and other clinical services s …
  • Nuvo Pharmaceuticals Inc (NRI):企業の財務・戦略的SWOT分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務情報
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Italgas SpA-石油・ガス分野:企業M&A・提携分析
    Summary Italgas SpA (Italgas), a subsidiary of Snam SpA, is an oilfield service company that offers transportation and dispatching of natural gas, liquefied natural gas regasification, and storage and distribution of natural gas. The company's activities include rhino-analytical tests; instrumental …
  • GNI Group Ltd (2160):製薬・医療:M&Aディール及び事業提携情報
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery, an …
  • Solid Biosciences Inc (SLDB):製薬・医療:M&Aディール及び事業提携情報
    Summary Solid Biosciences Inc (Solid Biosciences) is a life science company focused on developing therapies for duchenne muscular dystrophy (DMD). Its pipeline product candidates include SGT-001, a microdystrophin gene therapy administered through adeno-associated virus (AAV) stabilizes dystrophin g …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Reliance Naval and Engineering Ltd:企業のM&A・事業提携・投資動向
    Reliance Naval and Engineering Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reliance Naval and Engineering Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Applied Materials Inc (AMAT):電力:M&Aディール及び事業提携情報
    Summary Applied Materials Inc.(Applied Materials) is a provider of manufacturing equipment and software services.. The company provides semiconductors, displays, solar products, roll to roll web coating, emerging technologies and products and automation software. It caters its products and services …
  • XL-protein GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary XL-protein GmbH (XL-protein) is a biopharmaceutical company that develops second generation biopharmaceutical drugs. The company develops PASylation technology, designed to enable the biopharmaceuticals drug development with extended plasma half-life and enhanced action. It provides its tech …
  • Legend Holdings Corporation (3396):企業の財務・戦略的SWOT分析
    Legend Holdings Corporation (3396) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Porsche Automobil Holding SE (PAH3):企業の財務・戦略的SWOT分析
    Porsche Automobil Holding SE (PAH3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PORR AG (POS):企業の財務・戦略的SWOT分析
    PORR AG (POS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Shin Kong Financial Holding Co Ltd (2888):企業の財務・戦略的SWOT分析
    Shin Kong Financial Holding Co Ltd (2888) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆